Abstract
The purpose of this study was to determine if a panel of monoclonal antibodies could define phenotypic markers that could be used in risk assessment of a spectrum of colonic polypes and colon cancers. Using the ABC immunoperoxidase technique on formalin-fixed sections of surgical specimens, the following results were obtained: 1) Mab B72.3 demonstrated increased reactivity in villous lesions and cancers compared with hyperplastic polyps and tubular adenomas; 2) Mab anti-CAA demonstrated increased reactivity in polyps compared with colon cancers; and 3) using the two antibodies (Mab B72.3 and Mab anti-CAA), a malignancy ratio was obtained that determined malignancy risk for individual polyps. No hyperplastic polyp gave a positive ratio, but about 30 percent of villous lesions were positive. Over 50 percent of villous lesions greater than 2 cm in size had a positive ratio. The malignancy potential ratio may be a valuable marker in assessing risk of malignancy in an individual case.
Similar content being viewed by others
References
Prager ED, Swinton NW, Young JL, Veidenheimer MC, Corman ML. Follow-up study of patients with benign mucosal polyps discovered by proctosigmoidoscopy. Dis Colon Rectum 1974; 17: 322–4.
Jackman RJ, Mayo CW. The adenoma-carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 1951; 93: 327–42.
Gilbertson VA, Nelms JM. The prevention of invasive cancer of the rectum. Cancer 1978; 41: 1137–9.
Fenoglio CM, Lane N. The anatomic precursor of colorectal carcinoma. Cancer 1974; 34: 819–23.
Scarborough RA. The relationship between polyps and carcinoma of the colon and rectum. Dis Colon Rectum 1960; 3: 336–42.
Morson BC, Sobin LH. Histologic typing of intestinal tumors. World Health Organization, Geneva, Switzerland.
Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251–70.
Zinkin LD. A critical review of the classifications and staging of colorectal cancer. Dis Colon Rectum 1983; 26: 37–43.
Nuti M, Teramoto YA, Mariani-Constantini R, et al. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations. Int J Cancer 1982; 29: 539–45.
Stanick D, Schuss A, Mishriki Y, Lundy J. Reactivity of monoclonal antibody B72.3 with fetal antigen: correlation with expression of TAG-72 in human carcinomas. Cancer Invest 1988 (in press).
Muraro R, Wunderlich D, Thor A, et al. Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed, in human colon carcinomas versus normal adult tissues. Cancer Res 1985; 45: 5769–80.
Muraro R, Wunderlich D, Thor A, Cunningham R, Noguchi P, Schlom J. Immunologic characterization of a novel human colon-associated antigen (CAA) by a monoclonal antibody. Int J Cancer 1987; 39: 34–44.
Hsu SM, Raine L, Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577–80.
Lane N, Fenoglio CM, Kaye GI, et al. Defining the precursor tissue of ordinary large bowel cancer: implications for cancer prevention. In: Lipkin M, Good R, eds. Gastrointestinal tract: cancer. New York: Plenum, 1978.
Chesa PG, Rettig WJ, Melamed MR. Expression of cytokeratins in normal and neoplastic colonic epithelial cells. Am J Surg Pathol 1986; 10: 829–35.
Abe K, Hakomori S, Ohshiba S. Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different location of colonic epithelia, various histologic types of polyps, and adenocarcinoma. Cancer Res 1986; 46: 2639–44.
Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 289–303.
Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293–7.
Author information
Authors and Affiliations
About this article
Cite this article
Lundy, J., Schuss, A., Lyubsky, S. et al. Phenotypic markers for a spectrum of colonic polyps and cancers. Dis Colon Rectum 31, 857–863 (1988). https://doi.org/10.1007/BF02554849
Issue Date:
DOI: https://doi.org/10.1007/BF02554849